Skip to main content

Table 1 Baseline clinical characteristics of women with a history of menstrual disorders and controls

From: Effects of hormone replacement therapy on glucose and lipid metabolism in peri- and postmenopausal women with a history of menstrual disorders

Variable

Normal menstruation

(N = 530)

Menstrual disorders

(N = 65)

P valuea

Age (years)

47.70 ± 3.94

48.38 ± 4.06

0.22

Residence

 Urban

386 (72.83%)

50 (76.92%)

0.28

 Suburb

104 (19.62%)

8 (12.31%)

 Rural

40 (7.55%)

7 (10.77%)

Menstrual status

 Perimenopause, n (%)

410 (77.36%)

46 (70.77%)

0.24

 Postmenopause, n (%)

120 (22.64%)

19 (29.23%)

Age at menarche (years)

14.51 ± 1.56

14.97 ± 1.84

0.12

Gravidity

2.81 ± 1.35

2.83 ± 1.51

0.83

Parity

1.10 ± 0.44

1.14 ± 0.50

0.74

Height (m)

1.60 ± 0.05

1.59 ± 0.05

0.28

Weight (kg)

56.02 ± 6.93

55.75 ± 6.66

0.94

BMI (kg/m2)

21.94 ± 2.37

22.06 ± 2.37

0.59

 Underweight

22 (4.15%)

5 (7.69%)

0.27

 Normal weight

404 (76.23%)

48 (73.85%)

 Overweight

97 (18.30%)

10 (15.38%)

 Obesity

7 (1.32%)

2 (3.08%)

Waist circumference (cm)

75.98 ± 6.61

76.91 ± 7.15

0.38

Hip circumference (cm)

92.48 ± 5.05

92.27 ± 5.85

0.49

Waist to hip ratio

0.82 ± 0.05

0.83 ± 0.06

0.05

Hypertension, n (%)

 No

502 (94.72%)

60 (92.31%)

0.39

 Yes

28 (5.28%)

5 (7.69%)

  1. Data are expressed as numbers (frequencies) or mean ± standard deviation as appropriate. P < 0.05 was considered significant. aComparison between groups by Mann-Whitney U test/independent samples t-test for continuous variables or by χ2 test/Fisher’s exact test for categorical variables
  2. Others: BMI body mass index